Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Electro Optic Systems sees $99 million loss, rejigs the business from bottom up

  • In News
  • September 9, 2022
  • Alinda Gupta
Electro Optic Systems sees $99 million loss, rejigs the business from bottom up

What do you do when  you lose nearly $100 million in only six months? Re-evaluate everything. That’s exactly what defence, space and communications company Electro Optic Systems (ASX: EOS) is doing as it expresses disappointment in its first half result, losing $98.9 million in six months ending June 30, 2022. The loss is even more significant when compared with 1H 2021 when the Company lost $11.7 million.

EOS attributed over $54 million of the loss to the impairment of assets and onerous contracts held in SpaceLink Corporation, its satellite telecommunications arm. Additionally, revenues from ordinary activities, like customer delays, of $53.7 million represented a 45% reduction on the prior corresponding period ($97.8 million). EBITDA (excluding impairment) was a loss of $34 million.

No doubt, this year left a gaping hole in the Company’s wallet, which is why it is changing things up. For one, the Company announced that it is entering into a financing agreement with a major shareholder, Washington H. Soul Pattinson and Company Limited (WHSP). WHSP has refinanced an existing $35 million loan (on a short term basis) and provided an additional $20 million working capital facility to support the restructure of the Company’s core Defence and Space business.

On a foundational level, it is rehashing its leadership team to include managers with deep defence and commercial experience. The business model will be simplified to focus on the core defence and space tech businesses. 

Its restructure will allow the Company to prioritise businesses that are already profitable and respond to customer procurement activity rather than anticipating requirements through customer planning documents. These changes, including reductions in workforce and a simplified business plan, are expected to bring in at least $20 million of savings. 

Though the Company has not lost any customer contracts in the year, awarding of new contracts has been slower than expected in these months. In a bid to save money, EOS will be shutting down some of its facilities in Australia and the US and will reduce the HQ facility size by 50%. The Company expects these closures to save $1.5 million per year.

It is also reviewing its R&D spending, turning the attention to commercial investment criteria. It will also improve its sales and marketing campaigns in Asia, Europe and the US. 

EOS is also prioritising capital into the Defence and Space businesses so as to improve the commercialisation of SpaceLink. It continues to explore potential strategic and funding partners and investors who understand the specialised nature of the sector and its risk profile.

With regard to supply chain problems plaguing nearly every business right now, the Company expects these constraints to continue into H2, which may cause some revenue recognition to be delayed from H2 2022 into H1 2023.

The coming months will reveal whether the Company’s string of bad luck ends, and its new strategy proves effective.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • ASX: EOS
  • defence tech
  • Electro Optic Systems
  • EOS
  • spacelink
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.